Group 3 medulloblastoma in a patient with a GYS2 germline mutation and glycogen storage disease 0a

Childs Nerv Syst. 2018 Mar;34(3):581-584. doi: 10.1007/s00381-017-3666-9. Epub 2017 Nov 22.

Abstract

Glycogen storage disease (GSD) 0a is a rare congenital metabolic disease with symptoms in infancy and childhood caused by biallelic GYS2 germline variants. A predisposition to cancer has not been described yet. We report here a boy with GSD 0a, who developed a malignant brain tumor at the age of 4.5 years. The tumor was classified as a group 3 medulloblastoma, and the patient died from cancer 27 months after initial tumor diagnosis. This case appears interesting as group 3 medulloblastoma is so far not known to arise in hereditary syndromes and the biology of sporadic group 3 medulloblastoma is largely unknown.

Keywords: GYS2; Glycogen storage disease; Group 3 medulloblastoma.

Publication types

  • Case Reports

MeSH terms

  • Cerebellar Neoplasms / complications
  • Cerebellar Neoplasms / diagnostic imaging*
  • Cerebellar Neoplasms / genetics
  • Child, Preschool
  • Fatal Outcome
  • Germ-Line Mutation* / genetics
  • Glycogen Storage Disease / complications
  • Glycogen Storage Disease / diagnostic imaging*
  • Glycogen Storage Disease / genetics
  • Humans
  • Male
  • Medulloblastoma / complications
  • Medulloblastoma / diagnostic imaging*
  • Medulloblastoma / genetics